Physician profile
John Scott Heath
NPI 1881697985
$2,238.92
in general payments reported to CMS, 2019-2025
20 companies · $38.02 in 2025
The $38.02 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $939 · 2020: $105 · 2021: $86.03 · 2022: $195 · 2023: $321 · 2024: $555 · 2025: $38.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $914.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $707.92 | 2019-2024 | |
| Amgen INC. | $361.35 | 2019-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $162.07 | 2019-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $148.87 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $113.67 | 2024-2025 | Watchman Flx |
| Regeneron Healthcare Solutions, INC. | $110.30 | 2019-2022 | |
| Pfizer INC. | $108.53 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $86.12 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $76.20 | 2022-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.81 | 2019-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $55.25 | 2019-2023 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $42.06 | 2019-2023 | Brilinta |
| Braemar Manufacturing, LLC | $41.79 | 2019 | |
| Esperion Therapeutics, INC. | $37.41 | 2021-2023 | Nexletol |
| Edwards Lifesciences Corporation | $31.06 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $26.26 | 2019 | |
| Bardy Diagnostics, INC. | $24.69 | 2020-2021 | |
| Abiomed | $20.52 | 2024 | Impella |
| Astellas Pharma US INC | $15.97 | 2019 | |
| Baxter Healthcare | $13.07 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Heath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.